Biological Convergence of Cancer Signatures

Gene expression profiling has identified cancer prognostic and predictive signatures with superior performance to conventional histopathological or clinical parameters. Consequently, signatures are being incorporated into clinical practice and will soon influence everyday decisions in oncology. However, the slight overlap in the gene identity between signatures for the same cancer type or condition raises questions about their biological and clinical implications. To clarify these issues, better understanding of the molecular properties and possible interactions underlying apparently dissimilar signatures is needed. Here, we evaluated whether the signatures of 24 independent studies are related at the genome, transcriptome or proteome levels. Significant associations were consistently observed across these molecular layers, which suggest the existence of a common cancer cell phenotype. Convergence on cell proliferation and death supports the pivotal involvement of these processes in prognosis, metastasis and treatment response. In addition, functional and molecular associations were identified with the immune response in different cancer types and conditions that complement the contribution of cell proliferation and death. Examination of additional, independent, cancer datasets corroborated our observations. This study proposes a comprehensive strategy for interpreting cancer signatures that reveals common design principles and systems-level properties.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[3]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[4]  A. Grigoriev.  A relationship between gene expression and protein interactions on the proteome scale: analysis of the bacteriophage T7 and the yeast Saccharomyces cerevisiae. , 2001, Nucleic acids research.

[5]  G. Church,et al.  Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae , 2001, Nature Genetics.

[6]  M. Gerstein,et al.  Relating whole-genome expression data with protein-protein interactions. , 2002, Genome research.

[7]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[8]  C. Ball,et al.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.

[9]  P. Kemmeren,et al.  Protein interaction verification and functional annotation by integrated analysis of genome-scale data. , 2002, Molecular cell.

[10]  Alexander E. Kel,et al.  TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..

[11]  Levon M Khachigian,et al.  Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth , 2003, Nature Medicine.

[12]  Ash A. Alizadeh,et al.  Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.

[13]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[14]  M. Fernö,et al.  "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. , 2004, European journal of cancer.

[15]  Debashis Ghosh,et al.  Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data , 2004, BMC Genomics.

[16]  Dan Mercola,et al.  Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. , 2005, Cancer research.

[17]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[18]  Howard Y. Chang,et al.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Syed Mohsin,et al.  Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  T. Barrette,et al.  Mining for regulatory programs in the cancer transcriptome , 2005, Nature Genetics.

[21]  B. Vojtesek,et al.  Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  Bart De Moor,et al.  BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis , 2005, Bioinform..

[23]  J. Khan,et al.  Database of mRNA gene expression profiles of multiple human organs. , 2005, Genome research.

[24]  P. Jänne,et al.  Responsiveness to cetuximab without mutations in EGFR. , 2005, The New England journal of medicine.

[25]  Anthony Scime,et al.  Pocket Protein Complexes Are Recruited to Distinct Targets in Quiescent and Proliferating Cells , 2005, Molecular and Cellular Biology.

[26]  Gavin Sherlock,et al.  Of fish and chips , 2005, Nature Methods.

[27]  P. Jänne,et al.  Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Jeffrey T. Chang,et al.  GATHER: a systems approach to interpreting genomic signatures , 2006, Bioinform..

[29]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[30]  Dechang Chen,et al.  Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcome , 2007, BMC Genomics.

[31]  Patrick Kemmeren,et al.  Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. , 2006, Cancer research.

[32]  A. Nobel,et al.  The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.

[33]  S. Squazzo,et al.  A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data--a case study using E2F1. , 2006, Genome research.

[34]  Enrique Blanco,et al.  Transcription Factor Map Alignment of Promoter Regions , 2006, PLoS Comput. Biol..

[35]  A. Nobel,et al.  Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .

[36]  X. Solé,et al.  Integrative analysis of a cancer somatic mutome , 2007, Molecular Cancer.

[37]  W. Du,et al.  Retinoblastoma family genes , 2006, Oncogene.

[38]  L. Ein-Dor,et al.  Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Howard Y. Chang,et al.  Genetic regulators of large-scale transcriptional signatures in cancer , 2006, Nature Genetics.

[40]  J. Dopazo,et al.  Evidence for systems-level molecular mechanisms of tumorigenesis , 2007, BMC Genomics.

[41]  Urs Eppenberger,et al.  Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome , 2007, Breast Cancer Research.

[42]  R. Sutherland,et al.  Live or let die: oestrogen regulation of survival signalling in endocrine response , 2007, Breast Cancer Research.

[43]  C Hill,et al.  Interpretation of microarray data in cancer , 2007, British Journal of Cancer.

[44]  Purvesh Khatri,et al.  Onto-Tools: new additions and improvements in 2006 , 2007, Nucleic Acids Res..

[45]  J. Massagué.  Sorting out breast-cancer gene signatures. , 2007, The New England journal of medicine.

[46]  H. Ishikawa,et al.  Early growth response gene-1 plays a pivotal role in down-regulation of a cohort of genes in uterine leiomyoma. , 2007, Journal of molecular endocrinology.

[47]  Jill P. Mesirov,et al.  GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..

[48]  Fei Huang,et al.  Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring , 2007, Genome Biology.

[49]  Manuel Hidalgo,et al.  Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  I. Ellis,et al.  An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer , 2007, Genome Biology.

[51]  N. Kasabov,et al.  Multiple Gene Expression Classifiers from Different Array Platforms Predict Poor Prognosis of Colorectal Cancer , 2007, Clinical Cancer Research.

[52]  F. Bertucci,et al.  A gene signature in breast cancer. , 2007, The New England journal of medicine.

[53]  W. Woodward,et al.  A gene signature in breast cancer. , 2007, The New England journal of medicine.

[54]  Yi Zhang,et al.  Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer , 2007, BMC Cancer.

[55]  Seiichi Mori,et al.  An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. , 2008, Cancer cell.

[56]  Ole Winther,et al.  JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update , 2007, Nucleic Acids Res..

[57]  Jean-Marc Guinebretière,et al.  A six-gene signature predicting breast cancer lung metastasis. , 2008, Cancer research.

[58]  Debashis Ghosh,et al.  Pathway analysis reveals functional convergence of gene expression profiles in breast cancer , 2008 .

[59]  M. J. van de Vijver,et al.  Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity. , 2008, Seminars in radiation oncology.

[60]  Profiling of immune response to guide cancer diagnosis, prognosis, and prediction of therapy. , 2008, Cancer research.

[61]  S. Carotta,et al.  Critical roles for c-Myb in hematopoietic progenitor cells. , 2008, Seminars in immunology.

[62]  Lajos Pusztai,et al.  Gene expression profiling of breast cancer , 2009, Breast Cancer Research.